---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-041706"
form_type: "8-K"
ticker: "CELU"
cik: "0001752828"
company_name: "Celularity Inc"
filed_at: "2024-10-21T23:59:59+00:00"
generated_at: "2026-05-30T12:23:15.527515+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Celularity faces Nasdaq suspension Oct 25 for delinquent 10-Q filings; plans appeal

## Summary
- Nasdaq notified Celularity on Oct 16, 2024, that trading will be suspended Oct 25 due to failure to file Q1 and Q2 2024 10-Qs by Oct 14 extension deadline.
- Celularity intends to appeal Nasdaq's determination by Oct 23, 2024, under Listing Rule 5800 Series.
- If appeal is filed, trading continues during appeal process; no assurance of success in regaining compliance.
- Previously, on Aug 22, 2024, Nasdaq notified Celularity of non-compliance; exception granted until Oct 14, but forms still not filed.

## SEC filing metadata
- accession: 0001493152-24-041706
- form_type: 8-K
- ticker: CELU
- cik: 0001752828
- company_name: Celularity Inc
- filed_at: 2024-10-21T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1752828/000149315224041706/0001493152-24-041706-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1752828/000149315224041706/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-041706
- JSON: https://secwatch.observer/filing/0001493152-24-041706.json
- Plain text: https://secwatch.observer/filing/0001493152-24-041706.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.